Médicaments génériques

Generic Drugs
Therapeutic Area(s)
Development Stage
Launch Date
Group A (5 Products)
 Central Nervous System - Urology - Cardiovascular
 Under Regulatory Review
 2023Q2
Group B (3 Products)
 Central Nervous System - Gastrointestinal
 Under Regulatory Review
 2023Q3
Group C (1 Product)
 Oncology
 Under Regulatory Review
 2023Q4
Group D (8 Products)
 Central Nervous System - Cardiovascular - Metabolism
 Under Regulatory Review
 2024Q1
Group E (5 Products)
 Cardiovascular - Urology - Endocrinology
 Under Regulatory Review
 2024Q2
Group F (6 Products)
 Urology - Cardiovascular - Oncology - Anti-infectives
 Under Regulatory Review
 2024Q3